Background And Aims: Our ability to combat the opioid epidemic depends, in part, on dismantling the stigma that surrounds drug use. However, this epidemic has been unique and, to date, we have not understood the nature of public prejudices associated with it. Here, we examine the nature and magnitude of public stigma toward prescription opioid use disorder (OUD) using the only nationally representative data available on this topic.

Design: General Social Survey (GSS), a cross-sectional, nationally representative survey of public attitudes.

Setting: United States, 2018.

Participants/cases: A total of 1169 US residents recruited using a probability sample.

Measurements: Respondents completed a vignette-based survey experiment to assess public stigma toward people who develop OUD following prescription of opioid analgesics. This condition is compared with depression, schizophrenia, alcohol use disorder (AUD) and subclinical distress using multivariable logistic or linear regression.

Findings: Adjusting for covariates (e.g. race, age, gender), US residents were significantly more likely to label symptoms of OUD a physical illness [73%, confidence interval (CI) = 66-80%; P < 0.001] relative to all other conditions, and less likely to label OUD a mental illness (40%, CI = 32-48%; P < 0.001). OUD was significantly less likely to be attributed to bad character (37%, CI = 30-44%; P < 0.001) or poor upbringing (17%, CI = 12-23%; P < 0.001) compared with AUD. Nonetheless, perceptions of competence associated with OUD (e.g. ability to manage money; 41%, CI = 33-49%; P < 0.01) were lower than AUD, depression and subclinical distress. Moreover, willingness to socially exclude people with OUD was very high (e.g. 76% of respondents do not want to work with a person with OUD), paralleling findings on traditional targets of strong stigma (i.e. AUD and schizophrenia).

Conclusions: US residents do not typically hold people with prescription opioid use disorder responsible for their addiction, but they express high levels of willingness to subject them to social exclusion.

Download full-text PDF

Source
http://dx.doi.org/10.1111/add.15069DOI Listing

Publication Analysis

Top Keywords

public stigma
12
prescription opioid
12
nature public
8
nationally representative
8
public
5
unique nature
4
stigma
4
stigma non-medical
4
non-medical prescription
4
opioid
4

Similar Publications

Public perceptions of digital mental health awareness campaign in the Arab Gulf states: a qualitative thematic analysis.

Front Public Health

December 2024

Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Mental illness is a significant public health concern and a leading cause of disability worldwide. Research shows a lack of mental health knowledge and inappropriate practices in the Gulf Cooperation Council (GCC) states. Our study aimed to evaluate individuals' perspectives on mental health by analyzing their responses to a digital campaign directed at GCC adolescents.

View Article and Find Full Text PDF

Cancer is a leading cause of mortality worldwide. Despite its prevalence, its origins remain a topic of debate, sparking discussion within the medical and historical professions. It had been feared for centuries, initially perceived as an incurable condition fraught with social stigma.

View Article and Find Full Text PDF

Introduction HIV stigma levels are high in Greece. HIV stigma hinders testing, healthcare access, and treatment adherence, often leading to non-disclosure. The discloser navigates challenges by balancing the confidant's potential reactions, ranging from rejection and discrimination to the benefits of increased intimacy and liking.

View Article and Find Full Text PDF

Depression is a complex mental health condition characterized by persistent sadness, loss of interest, and a range of cognitive, emotional, and behavioral symptoms. It can be acute or chronic and is often influenced by a combination of genetic, biological, psychological, and social factors. According to transnational estimates of prevalence, depressive symptoms represent the most concerning challenge to mental health across cultures and beyond geographical borders.

View Article and Find Full Text PDF

Healthcare avoidance and delay among trans adults: Associations with mental and behavioral health outcomes.

Am J Prev Med

December 2024

Departments of Epidemiology and Health Systems and Population Health, University of Washington, Seattle, WA; Department of Social and Behavioral Sciences, Yale University, New Haven, CT.

Introduction: Healthcare avoidance and delay (HAD) is prevalent among transgender (trans) populations. This study sought to identify patterns of HAD and examine associations between HAD and 5 behavioral health outcomes among trans adults: depression, anxiety, tobacco and alcohol use, and intimate partner violence (IPV).

Methods: This study used survey data collected in 2023 from 789 trans adults in Washington state.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!